CompletedNCT02515773
Metformin and Lifestyle Support for Young People With Bipolarity Taking Antipsychotics
About this title
Read the official source — NCT02515773Medication studyAges 8–19United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 8 years to 19 years. Other eligibility criteria applied.
- Listed locations
- Covington and 28 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateDecember 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,565
- Sponsor
- Melissa Delbello
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 8 Years to 19 Years
- Official registry ID
- NCT02515773
- Official title
Show the full official title
MOBILITY- Metformin for Overweight & OBese ChILdren and Adolescents With BIpolar Spectrum Disorders Treated With Second-Generation AntipsYchotics
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Covington · Neptune City · Amityville
13 more locations
- Brooklyn
- Glen Oaks
- New York
- Queens
- Roslyn Heights
- Stony Brook
- Cincinnati
- Cleveland
- Columbus
- Dayton
- Hamilton
- Xenia
- Austin
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Melissa Delbello.
Did this study involve medication?
Yes. The study involved medication, including Metformin.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 8 years to 19 years. Other eligibility criteria applied.
